These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Determination of Arduan and its desacetyl metabolites in biological fluids. Gábor S; László V Acta Pharm Hung; 1989 Jul; 59(4):167-72. PubMed ID: 2549761 [TBL] [Abstract][Full Text] [Related]
23. Arduan, a new neuromuscular blocking agent. Fister T Ther Hung; 1983; 31(3):117-9. PubMed ID: 6100827 [No Abstract] [Full Text] [Related]
25. Summary of safety tests with pipecurium bromide, a new neuromuscular blocking agent. Cholnoky E Arzneimittelforschung; 1980; 30(2a):370-4. PubMed ID: 6248082 [TBL] [Abstract][Full Text] [Related]
26. Pipecurium bromide (Arduan)--new steroid non-depolarizing muscle relaxant. Kobielski J; Wysocki M; Orlicz P; Trzaski M; Gajewski K Ther Hung; 1986; 34(1):45-9. PubMed ID: 2833823 [No Abstract] [Full Text] [Related]
28. Synthesis of 2 beta,16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha,17 beta-diacetoxy-5 alpha-androstane dibromide and related compounds. Tuba Z Arzneimittelforschung; 1980; 30(2a):342-6. PubMed ID: 6248076 [TBL] [Abstract][Full Text] [Related]
29. Observations on the neuromuscular blocking action of pipecuronium in the dog. Jones RS Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005 [TBL] [Abstract][Full Text] [Related]
30. Disposition of pipecurium bromide in rats. Vereczkey L; Szporny L Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080 [TBL] [Abstract][Full Text] [Related]
31. Oto-rhino-laryngological interventions performed in arduan relaxation. Zelen B Ther Hung; 1985; 33(4):211-3. PubMed ID: 3020731 [No Abstract] [Full Text] [Related]
32. Observations made during operations performed under Arduan relaxation. Horváth I; Illés T Ther Hung; 1984; 32(1):13-5. PubMed ID: 6100828 [No Abstract] [Full Text] [Related]
33. First clinical experience with a new neuromuscular blocker pipecurium bromide. Alánt O; Darvas K; Pulay I; Weltner J; Bihari I Arzneimittelforschung; 1980; 30(2a):374-9. PubMed ID: 6248083 [TBL] [Abstract][Full Text] [Related]
34. Dose requirements and plasma concentrations of pipecuronium during bilateral renal exclusion and orthotopic liver transplantation in pigs. Pittet JF; Tassonyi E; Schopfer C; Morel DR; Leemann P; Mentha G; Le Coultre C; Steinig DA; Benakis A Br J Anaesth; 1990 Dec; 65(6):779-85. PubMed ID: 2176089 [TBL] [Abstract][Full Text] [Related]
35. [Antagonism of the neuromuscular block by pipecuronium bromide during anesthesia with isoflurane. A comparative study in elderly and adult patients]. Valeri R; Montorsi E; Gioia L; Martani C; Torri G Minerva Anestesiol; 1990 Sep; 56(9):899-903. PubMed ID: 2177168 [No Abstract] [Full Text] [Related]
36. Pharmacokinetics and disposition of pipecuronium bromide in the cat. Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702 [TBL] [Abstract][Full Text] [Related]
37. Comparative clinical study of pipecurium bromide and pancuronium bromide. Boros M; Szenohradszky J; Marosi G; Tóth I Arzneimittelforschung; 1980; 30(2a):389-93. PubMed ID: 6248087 [TBL] [Abstract][Full Text] [Related]
38. Report on clinical test of pipecurium bromide. Wittek L; Gecsényi M; Barna B; Hargitay Z; Adorján K Arzneimittelforschung; 1980; 30(2a):379-83. PubMed ID: 6248084 [TBL] [Abstract][Full Text] [Related]
39. [Kinetic study of the hydrolysis of pipecuronium bromide. III. General acid-base catalysis, effect of the solvent on the rate of hydrolysis]. Kovács P; Takácsi Nagy G; Horváth P Acta Pharm Hung; 1983 Mar; 53(2):71-85. PubMed ID: 6310954 [No Abstract] [Full Text] [Related]
40. Clinical experience with a new steroid muscle relaxant: pipecurium bromide. Bunjatjan AA; Miheev VI Arzneimittelforschung; 1980; 30(2a):383-5. PubMed ID: 6248085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]